Correction to: Preanalytic and Analytic Quality System Considerations in Noncoding RNA Biomarker Development for Clinical Diagnostics, by William S. Schleif, et al. Genet Test Mol Biomarkers 2023; (vol. 29, no. 5; 172-182); doi: 10.1089/gtmb.2022.0086.

IF 1.1 4区生物学 Q4 GENETICS & HEREDITY

Genetic testing and molecular biomarkers Pub Date : 2023-10-01 Epub Date: 2023-10-16 DOI:10.1089/gtmb.2022.0086.correx

引用次数: 0

更正：临床诊断用非编码RNA生物标记物开发中的预分析和分析质量系统考虑因素，William S.Schleif等人，Genet Test Mol Biomarkers 2023；（第29卷，第5号；172-182）；doi:10.1089/gtmb.2022.0086。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Genetic testing and molecular biomarkers 生物-遗传学

CiteScore

2.50

自引率

7.10%

发文量

审稿时长

1 months

期刊介绍： Genetic Testing and Molecular Biomarkers is the leading peer-reviewed journal covering all aspects of human genetic testing including molecular biomarkers. The Journal provides a forum for the development of new technology; the application of testing to decision making in an increasingly varied set of clinical situations; ethical, legal, social, and economic aspects of genetic testing; and issues concerning effective genetic counseling. This is the definitive resource for researchers, clinicians, and scientists who develop, perform, and interpret genetic tests and their results. Genetic Testing and Molecular Biomarkers coverage includes: -Diagnosis across the life span- Risk assessment- Carrier detection in individuals, couples, and populations- Novel methods and new instrumentation for genetic testing- Results of molecular, biochemical, and cytogenetic testing- Genetic counseling